Find a Top Oncologist Near Me – Book an Appointment Instantly

Gershwin Blyden, MD, PhD, FCP, FACP, is a board-certified hematologist-oncologist and medical director of The Foundation for Sickle Cell Disease Research, with locations in Homestead, Orlando, Lakeland, Jacksonville, Belle Glade, Tallahassee, and Hollywood, Florida. With more than 40 years of diverse experience, Dr. Blyden is an esteemed physician in his field.

After receiving his bachelor’s degree in plant science from the Tuskegee Institute (now Tuskegee University) in Tuskegee, Alabama, in 1967, Dr. Blyden earned a PhD in pharmacology from prestigious Yale University in New Haven, Connecticut, in 1976. Just three years later, he also earned his medical doctorate cum laude from Yale University.

In 1985, Dr. Blyden completed an internal medicine internship at Massachusetts General Hospital in Boston, Massachusetts. That same year, he also finished his hematology/oncology and clinical pharmacology fellowship at Tufts Medical Center in Boston, Massachusetts. 

After graduating and completing his training, Dr. Blyden worked as an adjunct professor for the Barry University School of Podiatric Medicine in Miami Shores, Florida, an associate clinical professor of hematology and oncology at the University of Miami School of Medicine in Miami, Florida, and as an associate professor of clinical pharmacy and director of the Clinical Pharmacology Research Unit at Florida A&M University’s Miami location.

Today, Dr. Blyden is a leader in the field of sickle cell treatment, case management, and research. He provides comprehensive care for chronic diseases, with a special emphasis on sickle cell anemia. 

Dr. Blyden offers a variety of infusion services, school individualized education program (IEP) support, transcranial Doppler ultrasounds, and more.

I grew up on a Maryland farm in a rural town with a population under 800. In my youth I walked to and from school and on weekends I rode horses with my friends. From a young age I showed a penchant for visual art but also science. I graduated from the University of Maryland with a bachelor’s in Graphic Design. Since there was no sufficient job market for designers in Maryland, I decided to move to Manhattan because I wanted to experience the art and culture that NYC had to offer. As it turned out, design work was a poor fit and I loathed sitting in an office all day staring at the monitor. I soon resigned and quickly became immersed in dance and acting. For the longest time, dance was my life. After performing for over 11 years, I longed to help people on a higher level and dreamed of a job that would satisfy my soul.
 

I moved to Arizona in 2012 and graduated from Southwest College of Naturopathic Medicine and Health Sciences in 2015. My primary interests include medical aesthetics, hormones and anti-aging, men’s and women’s health, endocrinology, and preventive wellness. In my spare time I like to stay physically active as much as possible. I am also a certified Pilates teacher. My hobbies include dance, theater, fine art, cooking, being outdoors, and traveling.

Kamlesh Kumar Sankhala MD (also known as Dr. Kumar by his patients and colleagues) is a Medical Oncologist at Cedars-Sinai Medical Center in Los Angeles, California, and Director of Precision NextGen Oncology and Research Center, an independent center focused on treatment of complex, rare cancer and Sarcomas, as well as, clinical research in Oncology for expedited drug development and clinical research. Precision NextGen Oncology and Research Center  focuses on care for patients with Advanced Cancers who are refractory to conventional treatments. We provide care to these patients with multi- institutional coordinated care and access to novel and next generation therapies with or without clinical trials.

Dr. Sankhala specializes in clinical research and has pioneered a niche in treatments for patients with advanced and complex malignancies refractory to conventional treatments, along with rare cancer such as sarcomas.

Dr. Sankhala received his medical degree at the University of Rajasthan, India and undertook his internal medicine residency and fellowship training in oncology at the University of Texas Health Science Center. He had two years of additional fellowship in Oncology Drug Development at the University of Texas’s Institute for Drug Development. He was a clinical faculty at the University of Texas’s Health Science Center, and Clinical Investigator at the Institute for Drug Development (IDD). He also served as team leader for the University’s Sarcoma Program. Dr. Sankhala has served as the Co-Director, Sarcoma Medical Oncology and the Director of Clinical Research and Experimental Therapeutics Cedars-Sinai Medical Center’s THO.

Besides his Medical Oncology practice in advanced refractory cancers, Dr. Sankhala’s research focuses on translational research of novel anti-cancer agents and on studying the pre-clinical and clinical aspects of these agents. With an esteemed background in novel drug research and phase-1 clinical trials, Dr. Sankhala has evolved into a physician devoted to the translational research of novel anti-cancer agents by applying himself to the study and evaluation of pre-clinical and clinical implications of new agents in patients with advanced cancers. He has developed a clinical proficiency in using novel anticancer drugs for patients with advanced malignancies and has optimized existing chemotherapeutic agents by reducing toxicities and increasing efficacy, thereby yielding better responses to anti-cancer therapies. Dr. Sankhala's extensive clinical research background includes serving as the principal investigator and sub-investigator in more than 250 Phase-1 and other Oncology clinical trials.

Dr. Sankhala has served on advisory boards for many pharmaceutical companies to design, implicate, and conduct research on many novel oncology therapeutic molecules and has also helped several other companies to optimize and find the marketplace for novel therapies. He has also served as a member of Protocol Review and Management Committee (PRMC) and institutional review board (IRB) at Samuel Oschin Cancer Center at Cedars-Sinai Cancer Institute in Los Angeles.

Dr. Sankhala has been a reviewer of reputed journals in the field of Oncology such as the British Journal of Cancer, Cancer Chemotherapy & Pharmacology, Journal of Medical Case Report, Onkologie, and Bone Marrow Transplantation. He is an editorial board member for the Journal of Cancer Science, and Therapy and Chemotherapy.

Dr. Sankhala’s has authored and co-authored 71 numerous articles, and abstracts in journals including Journal of Clinical Oncology, Clinical Cancer Research, Oncology immunology, Investigational New Drugs, Cancer Journal, Expert Review in Hematology, Cancer chemotherapy and Pharmacology, JAMA Oncology, Clinical Breast Cancer, Cancer Chemotherapy Pharmacology, Molecular Cancer Therapeutics, Leukemia Lymphoma, Current Drug Target, Expert Opinion in Investigational Drugs, Future Oncology, Target Oncology, Expert opinion in Drug Metabolism and Toxicology, and Clinical Advancement in Hematology Oncology.

He is the recipient of the American Society of Clinical Oncology Foundation’s Merit Award and the AACR- NCI scholarship for Molecular Biology in Clinical Oncology. 

He has presented in many major national and international meetings including the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), Japan’s Sarcoma Society, and many others. 

Beside Cedars-Sinai Medical Center, Dr. Sankhala has affiliations with various esteemed health facilities across Los Angeles, including Univversity of California at Los Angeles, University of Southern California and Providence Saint John's Health Center.

Dr. Sankhala’s academic interests extend to progressive fields including Healthcare Utilization Management, Managed Care, Consumer-Directed Healthcare, Healthcare Economics, and Medical Oncology Trend Management.

Steven Chen, MD, is a fellowship-trained oncologist surgeon who specializes in breast, endocrine, and melanoma surgery. Today, he is proud to work with the rest of the OasisMD team to help patients recover from the effects of cancer at OasisMD in Encinitas, San Diego, and Temecula, California. 

Dr. Chen completed both his undergraduate and medical degree at the University of Michigan in Ann Arbor, Michigan. He later performed his general surgery residency and critical care fellowship at the University of Michigan before moving to Los Angeles and completing a surgical oncology fellowship at the John Wayne Cancer Institute in Santa Monica, California.

Dr. Chen then joined the City of Hope, serving as the associate director of the Surgical Oncology Training Program. During his tenure there, Dr. Chen worked to train the next generation of surgical oncologists and served as the director of surgical oncology research. Dr. Chen also served as an associate professor of surgery. 

Throughout his career, Dr. Chen has also served as the chief of breast surgery and the chair of the Melanoma Tumor Board at the University of California, Davis Medical Center in Sacramento, California. His leadership ability led him to become a director of the American Society of Breast Surgeons and to assist in accrediting breast oncology training programs for the Society of Surgical Oncology. 

Dr. Chen has also held leadership positions in the American College of Surgeons, the American Medical Association, and the Association for Academic Surgery. A highly accomplished author, he has contributed to over 50 peer-reviewed medical publications, and he is often invited to deliver lectures all over the world. 

At OasisMD, Dr. Chen performs a variety of breast, thyroid, parathyroid, and melanoma procedures. He offers a wide range of oncology surgeries, including lumpectomy, mastectomy, and biopsy. Dr. Chen looks forward to continuing his work with cancer patients in the California area.

Steven Chen, MD, is a fellowship-trained oncologist surgeon who specializes in breast, endocrine, and melanoma surgery. Today, he is proud to work with the rest of the OasisMD team to help patients recover from the effects of cancer at OasisMD in Encinitas, San Diego, and Temecula, California. 

Dr. Chen completed both his undergraduate and medical degree at the University of Michigan in Ann Arbor, Michigan. He later performed his general surgery residency and critical care fellowship at the University of Michigan before moving to Los Angeles and completing a surgical oncology fellowship at the John Wayne Cancer Institute in Santa Monica, California.

Dr. Chen then joined the City of Hope, serving as the associate director of the Surgical Oncology Training Program. During his tenure there, Dr. Chen worked to train the next generation of surgical oncologists and served as the director of surgical oncology research. Dr. Chen also served as an associate professor of surgery. 

Throughout his career, Dr. Chen has also served as the chief of breast surgery and the chair of the Melanoma Tumor Board at the University of California, Davis Medical Center in Sacramento, California. His leadership ability led him to become a director of the American Society of Breast Surgeons and to assist in accrediting breast oncology training programs for the Society of Surgical Oncology. 

Dr. Chen has also held leadership positions in the American College of Surgeons, the American Medical Association, and the Association for Academic Surgery. A highly accomplished author, he has contributed to over 50 peer-reviewed medical publications, and he is often invited to deliver lectures all over the world. 

At OasisMD, Dr. Chen performs a variety of breast, thyroid, parathyroid, and melanoma procedures. He offers a wide range of oncology surgeries, including lumpectomy, mastectomy, and biopsy. Dr. Chen looks forward to continuing his work with cancer patients in the California area.

Christopher Ho, MD, is a physician at Wellness Oncology and Hematology. Dr. Ho treats cancer and hematology patients in West Hills and Tarzana, California, as part of the Wellness Oncology and Hematology medical team.

Dr. Ho was born and raised in Philadelphia. He earned his undergraduate degree from Johns Hopkins University in Baltimore, where he lettered in lacrosse, then returned to Philadelphia to earn his Doctor of Medicine from Temple University. While in medical school, he clerked at the Fox Chase Cancer Center in Philadelphia, an experience that ignited his interest in medical oncology research.

After a residency in internal medicine at the University of California, Davis, Dr. Ho received subspecialty training in medical oncology and hematology at the University of Southern California’s Keck School of Medicine in Los Angeles. He served as chief fellow of medical oncology.

Dr. Ho is certified by the American Board of Internal Medicine, the American Board of Medical Oncology, and the American Board of Hematology. To keep up with the latest advancements in his specialties, he retains active membership in the Medical Oncology Association of Southern California, the American Society of Hematology, and the American Society of Clinical Oncology.

Dr. Ho has dedicated himself to the belief that the health of every one of his patients depends on a comprehensive, personalized approach to care that includes a combination of the latest treatment techniques and the personal touch of a physician who truly cares.

Because of his wide range of interests, including music, nutrition, calisthenics, Philadelphia Eagles football, and gourmet food, Dr. Ho is able to connect easily with his patients and share insightful conversations. He is a devoted family man, spending as much time as possible with his wife and two young sons. He speaks English, Spanish, and Chinese.

Ashkan Lashkari, MD, is a physician at Wellness Oncology and Hematology. Dr. Lashkari offers personalized oncology and hematology care to patients at the practice’s offices in West Hills and Tarzana, California.

Born and raised in Santa Monica, California, by parents who were both dedicated educators, Dr. Lashkari knew at a young age that he wanted a career that would allow him to help others. He stayed close to home for his education, earning bachelor’s degrees in art history and molecular biology from the University of California at Los Angeles, and then remained at UCLA to complete his Doctor of Medicine degree.

During medical school, Dr. Lashkari developed a keen interest in cancer care, inspired by the discoveries of new treatments and the possibility of helping people with challenging conditions.

After an internal medicine residency at UCLA, Dr. Lashkari completed a fellowship in hematology and medical oncology at the City of Hope Comprehensive Cancer Center in Duarte, California. He focused his time on learning how to design clinical trials and researching familial cancer syndromes. His vast experience allows him to provide high-quality, compassionate care to his patients.

Dr. Lashkari is certified by the American Board of Internal Medicine, the American Board of Medical Oncology, and the American Board of Hematology. Because of his ongoing dedication to knowing about the latest oncology treatments and advances, he retains active membership in the Medical Oncology Association of Southern California, the American Society of Hematology, and the American Society of Clinical Oncology. He is also an assistant clinical faculty member at Olive View–UCLA Medical Center in Sylmar, California.

Dr. Lashkari enjoying spending time with his wife and two daughters, traveling, running, visiting museums, playing tennis, and cooking. He speaks English and Farsi.

Ashkan Lashkari, MD, is a physician at Wellness Oncology and Hematology. Dr. Lashkari offers personalized oncology and hematology care to patients at the practice’s offices in West Hills and Tarzana, California.

Born and raised in Santa Monica, California, by parents who were both dedicated educators, Dr. Lashkari knew at a young age that he wanted a career that would allow him to help others. He stayed close to home for his education, earning bachelor’s degrees in art history and molecular biology from the University of California at Los Angeles, and then remained at UCLA to complete his Doctor of Medicine degree.

During medical school, Dr. Lashkari developed a keen interest in cancer care, inspired by the discoveries of new treatments and the possibility of helping people with challenging conditions.

After an internal medicine residency at UCLA, Dr. Lashkari completed a fellowship in hematology and medical oncology at the City of Hope Comprehensive Cancer Center in Duarte, California. He focused his time on learning how to design clinical trials and researching familial cancer syndromes. His vast experience allows him to provide high-quality, compassionate care to his patients.

Dr. Lashkari is certified by the American Board of Internal Medicine, the American Board of Medical Oncology, and the American Board of Hematology. Because of his ongoing dedication to knowing about the latest oncology treatments and advances, he retains active membership in the Medical Oncology Association of Southern California, the American Society of Hematology, and the American Society of Clinical Oncology. He is also an assistant clinical faculty member at Olive View–UCLA Medical Center in Sylmar, California.

Dr. Lashkari enjoying spending time with his wife and two daughters, traveling, running, visiting museums, playing tennis, and cooking. He speaks English and Farsi.

Omid S. Shaye, MD, is an oncologist and hematologist at Wellness Oncology and Hematology. Dr. Shaye treats patients at the practice’s medical offices in West Hills and Tarzana, California.

Dr. Shaye is a native of the San Fernando Valley. He earned his undergraduate degree from the University of Southern California in Los Angeles, then remained at USC to complete his Doctor of Medicine.

During his residency and fellowship in hematology and oncology at the USC Norris Cancer Center, Dr. Shaye was chosen as chief fellow of medical oncology. He then established Wellness Oncology and Hematology in order to share the newest, most cutting-edge therapeutic options with cancer and hematology patients in the San Fernando Valley.

Dr. Shaye sees his role as the “quarterback of a patient’s care,” offering individualized treatments that can include options like targeted therapies, clinical trials, immunotherapies, chemotherapy, radiation, and surgery. He spends time getting to know his patients and their families as he helps them along the road to wellness.

Dr. Shaye is certified by the American Board of Internal Medicine and the American Board of Medical Oncology. He is a member of the Medical Oncology Association of Southern California, the Community Oncology Alliance, and the American Society of Clinical Oncology. He speaks English, Spanish, and Farsi.

Omid S. Shaye, MD, is an oncologist and hematologist at Wellness Oncology and Hematology. Dr. Shaye treats patients at the practice’s medical offices in West Hills and Tarzana, California.

Dr. Shaye is a native of the San Fernando Valley. He earned his undergraduate degree from the University of Southern California in Los Angeles, then remained at USC to complete his Doctor of Medicine.

During his residency and fellowship in hematology and oncology at the USC Norris Cancer Center, Dr. Shaye was chosen as chief fellow of medical oncology. He then established Wellness Oncology and Hematology in order to share the newest, most cutting-edge therapeutic options with cancer and hematology patients in the San Fernando Valley.

Dr. Shaye sees his role as the “quarterback of a patient’s care,” offering individualized treatments that can include options like targeted therapies, clinical trials, immunotherapies, chemotherapy, radiation, and surgery. He spends time getting to know his patients and their families as he helps them along the road to wellness.

Dr. Shaye is certified by the American Board of Internal Medicine and the American Board of Medical Oncology. He is a member of the Medical Oncology Association of Southern California, the Community Oncology Alliance, and the American Society of Clinical Oncology. He speaks English, Spanish, and Farsi.

Christopher Ho, MD, is a physician at Wellness Oncology and Hematology. Dr. Ho treats cancer and hematology patients in West Hills and Tarzana, California, as part of the Wellness Oncology and Hematology medical team.

Dr. Ho was born and raised in Philadelphia. He earned his undergraduate degree from Johns Hopkins University in Baltimore, where he lettered in lacrosse, then returned to Philadelphia to earn his Doctor of Medicine from Temple University. While in medical school, he clerked at the Fox Chase Cancer Center in Philadelphia, an experience that ignited his interest in medical oncology research.

After a residency in internal medicine at the University of California, Davis, Dr. Ho received subspecialty training in medical oncology and hematology at the University of Southern California’s Keck School of Medicine in Los Angeles. He served as chief fellow of medical oncology.

Dr. Ho is certified by the American Board of Internal Medicine, the American Board of Medical Oncology, and the American Board of Hematology. To keep up with the latest advancements in his specialties, he retains active membership in the Medical Oncology Association of Southern California, the American Society of Hematology, and the American Society of Clinical Oncology.

Dr. Ho has dedicated himself to the belief that the health of every one of his patients depends on a comprehensive, personalized approach to care that includes a combination of the latest treatment techniques and the personal touch of a physician who truly cares.

Because of his wide range of interests, including music, nutrition, calisthenics, Philadelphia Eagles football, and gourmet food, Dr. Ho is able to connect easily with his patients and share insightful conversations. He is a devoted family man, spending as much time as possible with his wife and two young sons. He speaks English, Spanish, and Chinese.

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Nimi Tuamokumo, MD MPH graduated cum laude from Princeton University with a Bachelor of Arts degree in the Psychology. She received her M.D. from Yale University School of Medicine in New Haven, CT and her MPH degree from Harvard School of Public Health.

Dr. Tuamokumo completed an internship in the Department of Medicine at Mount Auburn Hospital in Cambridge, MA and a residency in Radiation Oncology at the Harvard Radiation Oncology Program. Dr. Tuamokumo specializes in Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT).

She is experienced in treating all types of malignancies. Dr. Tuamokumo has been with GHRO since completion of her residency in 2008. She has received many awards, including the National Institutes of Health Careers in Medicine Fellowship, American Cancer Society Outstanding Thesis Award, New England Cancer Society’s Daland Resident Award, NIH Cancer Education Grant, Etta S. Chidsey Award in Cancer Research.

Dr. Tuamokumo has published articles and given presentations on a range of topics including breast cancer, prostate cancer, pediatric cancer, and gastric cancer. She is a member of the Texas Medical Association, the American Society of Clinical Oncology, and the American Society for Therapeutic Radiology and Oncology. 

Dr. Theodore K. Yang received his undergraduate degree at The University of Texas at Austin in physics and went on to work as a medical physicist before attending medical school. He received his medical degree and completed residency training in radiation oncology at The University of Texas Medical Branch at Galveston (UTMB).

He then joined the UTMB faculty specializing in head and neck therapy and brachytherapy. Board certified in therapeutic radiology, Dr. Yang has practiced radiation oncology Houston since 1984.

Dr. Yang is a member of professional medical societies, including the Harris County Medical Society, Texas Medical Association, American Medical Association, ASTRO (American Society for Therapeutic Radiology and Oncology) and CADAH (Chinese American Doctors Association of Houston). 

Cerebrum MD in Vienna, Virginia, was founded by board-certified neurosurgeon Joseph Watson, MD, and is dedicated to giving each patient access to innovative neurosurgical solutions. As specialists in neurological care, Dr. Watson and his team strive to provide truly personalized care and helping each patient understand and navigate their treatment options.

Patients choose Cerebrum MD when they need a skilled surgical team with extensive experience in brain tumors, pituitary tumors, and spinal tumors. They perform cerebral bypass surgery to restore blood flow to the brain when circulation is restricted due to a blocked artery. 

At Cerebrum MD, the team also successfully treats some of the most challenging conditions, such as brain aneurysms, trigeminal neuralgia, and brain and spine arteriovenous malformations. They also specialize in minimally invasive spinal surgery, safely treating problems such as spinal stenosis.

When patients need brain surgery, they can rely on comprehensive support from a team that understands the emotional challenges of making difficult decisions. From initial consultation and second opinions to surgery and post-operative care, every patient at Cerebrum MD receives respectful, informed attention and compassionate care.

To schedule an appointment or to find answers to difficult health conditions, call the office today.